Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study

Hepatology

Volumn 60, Issue 6, 2014, Pages 1963-1971

  Murphy, Gwen ^a   Michel, Angelika ^b   Taylor, Philip R ^a   Albanes, Demetrius ^a   Weinstein, Stephanie J ^a   Virtamo, Jarmo ^c   Parisi, Dominick ^d   Snyder, Kirk ^d   Butt, Julia ^b   Mcglynn, Katherine A ^a   Koshiol, Jill ^a   Pawlita, Michael ^b   Lai, Gabriel Y ^a   Abnet, Christian C ^a   Dawsey, Sanford M ^a   Freedman, Neal D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; BETA CAROTENE; CAGA PROTEIN; CHOLESTEROL; GLUCOSE; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; INSULIN; VITAMIN;

ADULT; ARTICLE; BACTERIUM DETECTION; BILE DUCT CANCER; BILIARY TRACT CANCER; BODY MASS; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; GALLBLADDER CANCER; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HELICOBACTER PYLORI; HUMAN; ICD-9; INSULIN BLOOD LEVEL; INTRAHEPATIC BILE DUCT CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BILIARY TRACT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CASE CONTROL STUDY; COMPLICATION; HELICOBACTER INFECTION; LIVER NEOPLASMS; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ALPHA-TOCOPHEROL; BETA CAROTENE; BILIARY TRACT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; HELICOBACTER INFECTIONS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMINS;

EID: 84912047241     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27193     Document Type: Article

References (49)

1. Leong RW, Sung JJ. Review article: Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 2002;16:1037-1045.
2. Pellicano R, Menard A, Rizzetto M, Megraud F. Helicobacter species and liver diseases: association or causation? Lancet Infect Dis 2008;8:254-260.
3. Hofmann AF. Helicobacter and cholesterol gallstones: do findings in the mouse apply to man? Gastroenterology 2005;128:1126-1129.
4. Suzuki H, Franceschi F, Nishizawa T, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2011;16(Suppl 1):65-69.
5. Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, Paster BJ, et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998;114:755-763.
6. Bulajic M, Maisonneuve P, Schneider-Brachert W, Muller P, Reischl U, Stimec B, et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 2002;95:1946-1953.
7. Bansal VK, Misra MC, Chaubal G, Datta Gupta S, Das B, Ahuja V, et al. Helicobacter pylori in gallbladder mucosa in patients with gallbladder disease. Indian J Gastroenterol 2012;31:57-60.
8. Zhou D, Zhang Y, Gong W, Mohamed SO, Ogbomo H, Wang X, et al. Are Helicobacter pylori and other Helicobacter species infection associated with human biliary lithiasis? A meta-analysis. PLoS One 2011;6:e27390.
9. Rocha M, Avenaud P, Menard A, Le Bail B, Balabaud C, Bioulac-Sage P, et al. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 2005;54:396-401.
10. Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR, et al. Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 2005;128:1023-1033.
11. Belzer C, Kusters JG, Kuipers EJ, van Vliet AH. Urease induced calcium precipitation by Helicobacter species may initiate gallstone formation. Gut 2006;55:1678-1679.
12. Fox JG, Dewhirst FE, Tully JG, Paster BJ, Yan L, Taylor NS, et al. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 1994;32:1238-1245.
13. Fox JG, Yan L, Shames B, Campbell J, Murphy JC, Li X. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun 1996;64:3673-3681.
14. Avenaud P, Le Bail B, Mayo K, Marais A, Fawaz R, Bioulac-Sage P, et al. Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvement. Infect Immun 2003;71:3667-3672.
15. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917.
16. Maurer KJ, Carey MC, Fox JG. Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology 2009;136:425-440.
17. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131.
18. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-1136.
19. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori Infection and the Development of Gastric Cancer. N Engl J Med 2001;345:784-789.
20. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991;302:1302-1305.
21. Epplein M, Zheng W, Xiang YB, Peek RM Jr, Li H, Correa P, et al. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev 2012;21:2185-2192.
22. Gao L, Michel A, Weck MN, Arndt V, Pawlita M, Brenner H. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res 2009;69:6164-6170.
23. Gao L, Weck MN, Michel A, Pawlita M, Brenner H. Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. Cancer Res 2009;69:2973-2980.
24. The ATBC cancer prevention study group. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994;4:1-10.
25. World Health Organization. International statistical classification of diseases and related health problems. Geneva, Switzerland; 1978.
26. Michel A, Waterboer T, Kist M, Pawlita M. Helicobacter pylori multiplex serology. Helicobacter 2009;14:525-535.
27. Fox JG, Feng Y, Theve EJ, Raczynski AR, Fiala JL, Doernte AL, et al. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 2010;59:88-97.
28. Ge Z, Feng Y, Muthupalani S, Eurell LL, Taylor NS, Whary MT, et al. Coinfection with Enterohepatic Helicobacter species can ameliorate or promote Helicobacter pylori-induced gastric pathology in C57BL/6 mice. Infect Immun 2011;79:3861-3871.
29. Lemke LB, Ge Z, Whary MT, Feng Y, Rogers AB, Muthupalani S, et al. Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori-induced gastric pathology. Infect Immun 2009;77:2147-2158.
30. Ge Z, Lee A, Whary MT, Rogers AB, Maurer KJ, Taylor NS, et al. Helicobacter hepaticus urease is not required for intestinal colonization but promotes hepatic inflammation in male A/JCr mice. Microb Pathog 2008;45:18-24.
31. Garcia A, Feng Y, Parry NM, McCabe A, Mobley MW, Lertpiriyapong K, et al. Helicobacter pylori infection does not promote hepatocellular cancer in a transgenic mouse model of hepatitis C virus pathogenesis. Gut Microbes 2013;4:577-590.
32. Fox JG, Shen Z, Muthupalani S, Rogers AR, Kirchain SM, Dewhirst FE. Chronic hepatitis, hepatic dysplasia, fibrosis, and biliary hyperplasia in hamsters naturally infected with a novel Helicobacter classified in the H. bilis cluster. J Clin Microbiol 2009;47:3673-3681.
33. Kawaguchi M, Saito T, Ohno H, Midorikawa S, Sanji T, Handa Y, et al. Bacteria closely resembling Helicobacter pylori detected immunohistologically and genetically in resected gallbladder mucosa. J Gastroenterol 1996;31:294-298.
34. Apostolov E, Al-Soud WA, Nilsson I, Kornilovska I, Usenko V, Lyzogubov V, et al. Helicobacter pylori and other Helicobacter species in gallbladder and liver of patients with chronic cholecystitis detected by immunological and molecular methods. Scand J Gastroenterol 2005;40:96-102.
35. Avenaud P, Marais A, Monteiro L, Le Bail B, Bioulac Sage P, Balabaud C, et al. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 2000;89:1431-1439.
36. Fan XG, Peng XN, Huang Y, Yakoob J, Wang ZM, Chen YP. Helicobacter species ribosomal DNA recovered from the liver tissue of chinese patients with primary hepatocellular carcinoma. Clin Infect Dis 2002;35:1555-1557.
37. Huang Y, Fan XG, Wang ZM, Zhou JH, Tian XF, Li N. Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol 2004;57:1273-1277.
38. de Magalhaes Queiroz DM, Santos A. Isolation of a Helicobacter strain from the human liver. Gastroenterology 2001;121:1023-1024.
39. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;87:1777-1780.
40. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995;270:17771-17777.
41. Kavermann H, Burns BP, Angermuller K, Odenbreit S, Fischer W, Melchers K, et al. Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med 2003;197:813-822.
42. Fox JG, Wang TC. Helicobacter pylori-not a good bug after all! N Engl J Med 2001;345:829-832.
43. Matsukura N, Yokomuro S, Yamada S, Tajiri T, Sundo T, Hadama T, et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res 2002;93:842-847.
44. Pisani P, Whary MT, Nilsson I, Sriamporn S, Wadstrom T, Fox JG, et al. Cross-reactivity between immune responses to Helicobacter bilis and Helicobacter pylori in a population in Thailand at high risk of developing cholangiocarcinoma. Clin Vaccine Immunol 2008;15:1363-1368.
45. Maurer KJ, Rogers AB, Ge Z, Wiese AJ, Carey MC, Fox JG. Helicobacter pylori and cholesterol gallstone formation in C57L/J mice: a prospective study. Am J Physiol Gastrointest Liver Physiol 2006;290:G175-182.
46. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006;98:1445-1452.
47. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, Perez-Perez G, Taylor PR, Virtamo J, et al. Helicobacter pylori Seropositivity as a Risk Factor for Pancreatic Cancer. J. Natl. Cancer Inst. 2001;93:937-941.
48. Nilsson I, Shabo I, Svanvik J, Monstein HJ. Multiple displacement amplification of isolated DNA from human gallstones: molecular identification of Helicobacter DNA by means of 16S rDNA-based pyrosequencing analysis. Helicobacter 2005;10:592-600.
49. Fukuda K, Kuroki T, Tajima Y, Tsuneoka N, Kitajima T, Matsuzaki S, et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 2002;23:1927-1931.